WASHINGTON — Glucagon-like peptide-1 receptor agonists were associated with lower risk for progression to cirrhosis and hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease and type 2 diabetes.
“Metabolic dysfunction-associated steatotic liver disease, or MASLD, is a growing cause of cirrhosis and HCC,” Fasiha Kanwal, MD, MSHS,
Biden administration defends treatment of veterans despite IG report – The Center Square prescottenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prescottenews.com Daily Mail and Mail on Sunday newspapers.
AI as Cancer Oracle? | Harvard Magazine harvardmagazine.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from harvardmagazine.com Daily Mail and Mail on Sunday newspapers.
WASHINGTON – U.S. Rep. Garret Graves asked the U.S. Department of Veterans Affairs to reverse a decision not to proceed with the Baton Rouge V.A. Outpatient Clinic expansion because of